UniProt ID | XRN2_MOUSE | |
---|---|---|
UniProt AC | Q9DBR1 | |
Protein Name | 5'-3' exoribonuclease 2 | |
Gene Name | Xrn2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 951 | |
Subcellular Localization | Nucleus, nucleolus . | |
Protein Description | Possesses 5'->3' exoribonuclease activity. May promote the termination of transcription by RNA polymerase II. During transcription termination, cleavage at the polyadenylation site liberates a 5' fragment which is subsequently processed to form the mature mRNA and a 3' fragment which remains attached to the elongating polymerase. The processive degradation of this 3' fragment by this protein may promote termination of transcription. Binds to RNA polymerase II (RNAp II) transcription termination R-loops formed by G-rich pause sites (By similarity).. | |
Protein Sequence | MGVPAFFRWLSRKYPSIIVNCVEEKPKECNGVKIPVDASKPNPNDVEFDNLYLDMNGIIHPCTHPEDKPAPKNEDEMMVAIFEYIDRLFNIVRPRRLLYMAIDGVAPRAKMNQQRSRRFRASKEGMEAAVEKQRVREEILAKGGFLPPEEIKERFDSNCITPGTEFMDNLAKCLRYYIADRLNNDPGWKNLTVILSDASAPGEGEHKIMDYIRRQRAQPNHDPNTHHCLCGADADLIMLGLATHEPNFTIIREEFKPNKPKPCALCNQFGHEVKDCEGLPREKKGKHDELADSLPCAEGEFIFLRLNVLREYLERELTMASLPFPFDVERSIDDWVFMCFFVGNDFLPHLPSLEIREGAIDRLVNIYKNVVHKTGGYLTESGYVNLQRVQMIMLAVGEVEDSIFKKRKDDEDSFRRRQKEKRKRMKRDQPAFTPSGILTPHALGSRNSPGCQVASNPRQAAYEMRMQRNSSPSISPNTSFASDGSPSPLGGIKRKAEDSDSEPEPEDNVRLWEAGWKQRYYKNKFDVDAADEKFRRKVVQSYVEGLCWVLRYYYQGCASWKWYYPFHYAPFASDFEGIADMSSEFEKGTKPFKPLEQLMGVFPAASGNFLPPTWRKLMSDPDSSIIDFYPEDFAIDLNGKKYAWQGVALLPFVDERRLRAALEEVYPDLTPEENRRNSLGGDVLFVGKLHPLRDFILELYQTGSTEPVDVPPELCHGIQGTFSLDEEAILPDQTVCSPVPMLRDLTQNTAVSINFKDPQFAEDYVFKAAMLPGARKPATVLKPGDWEKSSNGRQWKPQLGFNRDRRPVHLDQAAFRTLGHVTPRGSGTSVYTNTALPPANYQGNNYRPLLRGQAQIPKLMSNMRPQDSWRGPPPLFQQHRFERSVGAEPLLPWNRMIQNQNAAFQPNQYQMLGGPGGYPPRRDDHRGGRQGYPREGRKYPLPPPSGRYSWN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
286 | Acetylation | LPREKKGKHDELADS CCCCCCCCCCHHHHH | 57.68 | 23806337 | |
406 | Acetylation | VEDSIFKKRKDDEDS CCHHHHHHCCCCHHH | 54.66 | 30988531 | |
433 | Phosphorylation | KRDQPAFTPSGILTP CCCCCCCCCCCCCCH | 20.74 | 26160508 | |
435 | Phosphorylation | DQPAFTPSGILTPHA CCCCCCCCCCCCHHH | 35.09 | 25266776 | |
439 | Phosphorylation | FTPSGILTPHALGSR CCCCCCCCHHHCCCC | 15.88 | 26745281 | |
445 | Phosphorylation | LTPHALGSRNSPGCQ CCHHHCCCCCCCCCC | 29.19 | 26160508 | |
448 | Phosphorylation | HALGSRNSPGCQVAS HHCCCCCCCCCCCCC | 22.89 | 25521595 | |
455 | Phosphorylation | SPGCQVASNPRQAAY CCCCCCCCCHHHHHH | 48.81 | 25266776 | |
470 | Phosphorylation | EMRMQRNSSPSISPN HHHHHHCCCCCCCCC | 45.90 | 25521595 | |
471 | Phosphorylation | MRMQRNSSPSISPNT HHHHHCCCCCCCCCC | 26.64 | 27087446 | |
473 | Phosphorylation | MQRNSSPSISPNTSF HHHCCCCCCCCCCCC | 37.33 | 25521595 | |
475 | Phosphorylation | RNSSPSISPNTSFAS HCCCCCCCCCCCCCC | 19.21 | 25521595 | |
478 | Phosphorylation | SPSISPNTSFASDGS CCCCCCCCCCCCCCC | 28.71 | 27087446 | |
479 | Phosphorylation | PSISPNTSFASDGSP CCCCCCCCCCCCCCC | 26.00 | 27087446 | |
482 | Phosphorylation | SPNTSFASDGSPSPL CCCCCCCCCCCCCCC | 40.26 | 27087446 | |
485 | Phosphorylation | TSFASDGSPSPLGGI CCCCCCCCCCCCCCC | 27.48 | 25521595 | |
487 | Phosphorylation | FASDGSPSPLGGIKR CCCCCCCCCCCCCCC | 34.16 | 25521595 | |
493 | Ubiquitination | PSPLGGIKRKAEDSD CCCCCCCCCCCCCCC | 51.63 | - | |
499 (in isoform 2) | Phosphorylation | - | 34.24 | 19144319 | |
499 | Phosphorylation | IKRKAEDSDSEPEPE CCCCCCCCCCCCCCH | 34.24 | 27087446 | |
501 (in isoform 2) | Phosphorylation | - | 60.03 | 19144319 | |
501 | Phosphorylation | RKAEDSDSEPEPEDN CCCCCCCCCCCCHHH | 60.03 | 27087446 | |
533 | Ubiquitination | DVDAADEKFRRKVVQ CCHHHCHHHHHHHHH | 44.72 | - | |
640 | Acetylation | FAIDLNGKKYAWQGV EEEECCCCEEEEEEE | 41.35 | 22361613 | |
641 | Acetylation | AIDLNGKKYAWQGVA EEECCCCEEEEEEEE | 41.41 | 22826441 | |
666 | Phosphorylation | RAALEEVYPDLTPEE HHHHHHHCCCCCHHH | 8.36 | 27717184 | |
670 | Phosphorylation | EEVYPDLTPEENRRN HHHCCCCCHHHHHCC | 35.71 | 29514104 | |
678 | Phosphorylation | PEENRRNSLGGDVLF HHHHHCCCCCCCEEE | 26.95 | 26824392 | |
688 | Ubiquitination | GDVLFVGKLHPLRDF CCEEEEECCCCHHHH | 38.02 | - | |
796 | Ubiquitination | SSNGRQWKPQLGFNR CCCCCCCCCCCCCCC | 17.97 | - | |
817 | Phosphorylation | LDQAAFRTLGHVTPR HHHHHHHHHCCCCCC | 30.55 | 29176673 | |
824 | Methylation | TLGHVTPRGSGTSVY HHCCCCCCCCCCEEE | 42.41 | 26542391 | |
824 | Asymmetric dimethylarginine | TLGHVTPRGSGTSVY HHCCCCCCCCCCEEE | 42.41 | - | |
826 | Phosphorylation | GHVTPRGSGTSVYTN CCCCCCCCCCEEEEC | 39.93 | 25293948 | |
828 | Phosphorylation | VTPRGSGTSVYTNTA CCCCCCCCEEEECCC | 19.40 | 25293948 | |
829 | Phosphorylation | TPRGSGTSVYTNTAL CCCCCCCEEEECCCC | 19.36 | 25293948 | |
831 | Phosphorylation | RGSGTSVYTNTALPP CCCCCEEEECCCCCC | 8.27 | 25293948 | |
832 | Phosphorylation | GSGTSVYTNTALPPA CCCCEEEECCCCCCC | 24.76 | 25293948 | |
834 | Phosphorylation | GTSVYTNTALPPANY CCEEEECCCCCCCCC | 23.05 | 25293948 | |
841 | Phosphorylation | TALPPANYQGNNYRP CCCCCCCCCCCCCHH | 21.65 | 25293948 | |
846 | Phosphorylation | ANYQGNNYRPLLRGQ CCCCCCCCHHHHCCC | 20.01 | 25293948 | |
847 | Asymmetric dimethylarginine | NYQGNNYRPLLRGQA CCCCCCCHHHHCCCC | 19.95 | - | |
847 | Methylation | NYQGNNYRPLLRGQA CCCCCCCHHHHCCCC | 19.95 | 24129315 | |
851 | Asymmetric dimethylarginine | NNYRPLLRGQAQIPK CCCHHHHCCCCHHHH | 42.75 | - | |
851 | Methylation | NNYRPLLRGQAQIPK CCCHHHHCCCCHHHH | 42.75 | 54560683 | |
864 | Dimethylation | PKLMSNMRPQDSWRG HHHHHCCCCCCCCCC | 29.94 | - | |
864 | Methylation | PKLMSNMRPQDSWRG HHHHHCCCCCCCCCC | 29.94 | 54560643 | |
870 | Dimethylation | MRPQDSWRGPPPLFQ CCCCCCCCCCCCHHH | 52.25 | - | |
870 | Methylation | MRPQDSWRGPPPLFQ CCCCCCCCCCCCHHH | 52.25 | 54560659 | |
880 | Asymmetric dimethylarginine | PPLFQQHRFERSVGA CCHHHHHCHHCCCCC | 30.68 | - | |
880 | Methylation | PPLFQQHRFERSVGA CCHHHHHCHHCCCCC | 30.68 | 24129315 | |
883 | Asymmetric dimethylarginine | FQQHRFERSVGAEPL HHHHCHHCCCCCCCC | 33.65 | - | |
883 | Methylation | FQQHRFERSVGAEPL HHHHCHHCCCCCCCC | 33.65 | 24129315 | |
895 | Methylation | EPLLPWNRMIQNQNA CCCCCHHHHHCCCCC | 21.51 | 24129315 | |
945 | Phosphorylation | KYPLPPPSGRYSWN- CCCCCCCCCCCCCC- | 41.50 | 26643407 | |
947 | Asymmetric dimethylarginine | PLPPPSGRYSWN--- CCCCCCCCCCCC--- | 27.01 | - | |
947 | Methylation | PLPPPSGRYSWN--- CCCCCCCCCCCC--- | 27.01 | 24129315 | |
948 | Phosphorylation | LPPPSGRYSWN---- CCCCCCCCCCC---- | 22.89 | 26643407 | |
949 | Phosphorylation | PPPSGRYSWN----- CCCCCCCCCC----- | 20.84 | 26643407 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
439 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of XRN2_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of XRN2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of XRN2_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499 AND SER-501, ANDMASS SPECTROMETRY. | |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-448; SER-499 ANDSER-501, AND MASS SPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499 AND SER-501, ANDMASS SPECTROMETRY. | |
"A differential phosphoproteomic analysis of retinoic acid-treated P19cells."; Smith J.C., Duchesne M.A., Tozzi P., Ethier M., Figeys D.; J. Proteome Res. 6:3174-3186(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499 AND SER-501, ANDMASS SPECTROMETRY. |